...
首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Diagnosis of iodide transport defect: do we need to measure the saliva/serum radioactive iodide ratio to diagnose iodide transport defect?
【24h】

Diagnosis of iodide transport defect: do we need to measure the saliva/serum radioactive iodide ratio to diagnose iodide transport defect?

机译:碘化物运输缺陷的诊断:我们需要测量唾液/血清放射性碘化物的比例来诊断碘化物运输缺陷吗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Iodide transport defect (ITD) is an infrequent condition associated with congenital dyshormonogenetic goiter due to mutations in the Na(+)/I(-) symporter (NIS) gene transmitted in an autosomal recessive manner. Herein, we describe a patient with ITD and discuss the features important for the diagnosis, focusing on whether or not measuring the saliva/serum radioactive iodide ratio is useful. SUMMARY: A 42-year-old Japanese man attended our hospital in 2010. At that time, he had been off L-thyroxine for several months. He had no obvious mental retardation. His parents were cousins and his sister also had a goiter. Since thyroid dyshormonogenesis could not be ruled out, thyroid function tests, scintigraphy, and ultrasonography were performed. The results showed marked hypothyroidism with a high thyroglobulin level of 627 ng/mL. The results for thyroglobulin antibody and thyroid peroxidase antibody were both negative. Ultrasonography showed an enlarged thyroid gland. Neither the thyroid nor the salivary gland was visualized by (99m)TcO(4)(-) scintigraphy. Therefore, we performed genetic testing for the NIS gene without measuring the saliva/serum radioactive iodide ratio. A homozygous mutation, T354P, was identified in the NIS gene. On the basis of this finding, we could make the definitive diagnosis of ITD due to an NIS mutation. CONCLUSIONS: We recommend confirming the presence of the thyroid by ultrasonography of the neck first and then performing (99m)TcO(4)(-) scintigraphy. If neither the salivary gland nor the thyroid is visualized, screening for NIS mutations should be undertaken. This approach obviates the need to undertake measurement of the saliva/serum radioactive iodide ratio to diagnose ITD.
机译:背景:碘化物运输缺陷(ITD)是由于以常染色体隐性方式传播的Na(+)/ I(-)转运蛋白(NIS)基因突变引起的与先天性失调性甲状腺肿相关的罕见病。在此,我们将介绍ITD患者并讨论对诊断重要的功能,重点是测量唾液/血清放射性碘化物的比例是否有用。摘要:2010年,一名42岁的日本男子到我们医院就诊。当时,他已经停用L-甲状腺素几个月了。他没有明显的智力障碍。他的父母是表兄弟,姐姐也有甲状腺肿。由于不能排除甲状腺功能紊乱,因此进行了甲状腺功能检查,闪烁显像和超声检查。结果显示甲状腺功能低下,甲状腺球蛋白水平高达627 ng / mL。甲状腺球蛋白抗体和甲状腺过氧化物酶抗体的结果均为阴性。超声检查显示甲状腺肿大。 (99m)TcO(4)(-)闪烁显像术既未显示甲状腺也未显示唾液腺。因此,我们对NIS基因进行了基因测试,而没有测量唾液/血清放射性碘的比率。在NIS基因中鉴定出纯合突变T354P。基于这一发现,我们可以对NIS突变引起的ITD做出明确的诊断。结论:我们建议先通过颈部超声检查确认甲状腺的存在,然后再进行(99m)TcO(4)(-)闪烁显像。如果唾液腺和甲状腺均未可见,则应进行NIS突变筛查。这种方法消除了进行唾液/血清放射性碘比测量以诊断ITD的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号